Ziac Dosage

The recommended starting dosage of Ziac for the treatment of high blood pressure is typically 2.5 mg/6.25 mg once a day. If your blood pressure does not improve, your healthcare provider may increase this amount up to a maximum of 20 mg/12.5 mg daily. If you were taking bisoprolol and hydrochlorothiazide separately, your healthcare provider will switch you to the equivalent Ziac dose.

An Introduction to Dosing With Ziac

The dose of Ziac® (bisoprolol and hydrochlorothiazide) your healthcare provider recommends will vary, depending on a number of factors, including:
 
  • The severity of your high blood pressure
  • How you respond to Ziac
  • Other medications you are taking
  • Other medical conditions you may have.
     
As is always the case, do not adjust your dosage unless your healthcare provider specifically instructs you to do so.
 

Recommended Ziac Dosage

For most people, the starting Ziac dose for the treatment of high
 blood pressure is 2.5 mg/6.25 mg once daily (this provides 2.5 mg of bisoprolol and 6.25 mg of hydrochlorothiazide). If necessary, your healthcare provider may increase this amount up to a maximum of 20 mg/12.5 mg once daily.
 
Of course, if you are switching from bisoprolol and hydrochlorothiazide taken separately, your healthcare provider will just switch you to the equivalent dose of Ziac.
 
For people with kidney disease, liver disease, or breathing problems such as asthma or chronic obstructive pulmonary disease (COPD), a lower starting dosage of Ziac may be recommended.
 
As with all beta blockers, you should not abruptly stop taking Ziac, as serious problems (including heart attacks) may result. Your healthcare provider will advise you about how to safely stop taking this medication. People are generally advised to slowly reduce the dose over time, with careful monitoring, and to minimize physical activity. Let your healthcare provider know if you develop chest pain or any other problems while stopping treatment.
 
(Ziac Dosage Continued: Page 2)
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;
Other Articles in This eMedTV Presentation